Inhibition of PAF-induced expression of CD11b and shedding of L-selectin on human neutrophils and eosinophils by the type IV selective PDE inhibitor, rolipram

European Respiratory Journal

Volumn 10, Issue 5, 1997, Pages 1000-1007

  Berends, C ^a   Dijkhuizen, B ^a   De Monchy, J G R ^a   Dubois, A E J ^a   Gerritsen, J ^a   Kauffman, H F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

eosinophils; L selectin; neutrophils; phosphodiesterase inhibitors; rolipram

Indexed keywords

CD11B ANTIGEN; ISOPRENALINE; MONOCLONAL ANTIBODY; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E2; ROLIPRAM; SELECTIN; THROMBOCYTE ACTIVATING FACTOR;

ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; NEUTROPHIL; NORMAL HUMAN; PNEUMONIA; PRIORITY JOURNAL;

EID: 0030922428     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10051000     Document Type: Article

References (49)

1. de Monchy JGR, Kauffman HF, Venge P, et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373-376.
2. Hansel T, Walker C. The migration of eosinophils into the sputum of asthmatics: the role of adhesion molecules. Clin Exp Allergy 1992; 22: 345-356.
3. Tate RM, Repine JE. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 1983; 28: 552-559.
4. Bruijnzeel PLB. Contribution of eosinophil-derived mediators in asthma. Int Arch Allergy Appl Immunol 1989; 90: 57-63.
5. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376.
6. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
7. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 1994; 94: 427-438.
8. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991; 65: 859-873.
9. 2-integrins in vivo. Proc Natl Acad Sci USA 1991; 88: 7538-7542.
10. O'Shea J, Brown EJ, Seligmann BE, Metcalf JA, Frank M, Gallin JI. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J Immunol 1985; 134: 2580-2587.
11. Zimmerman GA, McIntyre TM, Mehra M, Prescott SM. Endothelial cell-associated platelet-activating factor: a novel mechanism for signalling intercellular adhesion. J Cell Biol 1990; 110: 529-540.
12. Neeley SP, Hamann KJ, White SR, Baranowski SL, Burch RA, Leff AR. Selective regulation of expression of surface adhesion molecules, Mac-1, L-selectin and VLA-4, on human eosinophils and neutrophils. Am J Respir Cell Mol Biol 1993; 8: 633-639.
13. Walker C, Rihs S, Braun RK, Betz S, Bruijnzeel PLB. Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers. J Immunol 1993; 150: 4061-4071.
14. Mengelers HJ, Maikoe T, Hooibrink B, et al. Down-modulation of L-selectin expression on eosinophils recovered from bronchoalveolar lavage fluid after allergen provocation. Clin Exp Allergy 1993; 23: 196-204.
15. Georas SN, Liu MC, Newman W, Beall LD, Stealey BA, Bochner BS. Altered adhesion molecule expression and endothelial cell activation accompany the recruitment of the human granulocytes to the lung after segmental antigen challenge. Am J Respir Cell Mol Biol 1992; 7: 261-269.
16. Newsholme SJ, Schwartz L. cAMP-specific phosphodiesterase inhibitor, rolipram, reduces eosinophil infiltration evoked by leukotrienes or by histamine in guinea-pig conjunctiva. Inflammation 1993; 17: 25-31.
17. Underwood DC, Osborn R, Novak LB, et al. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea-pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. J Pharmacol Exp Ther 1993; 266: 306-313.
18. Griswold DE, Webb EF, Breton J, White JR, Marshall PJ, Torphy TJ. Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response. Inflammation 1993; 17: 333-344.
19. Torphy TJ, Undem BJ. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 1991; 46: 512-523.
20. Dent G, Giembycz MA, Rabe KF, Barnes PJ. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by "type IV"-selective PDE inhibitors. Br J Pharmacol 1991; 103: 1339-1346.
21. Poison JB, Krzanowski J, Szentivanyi A. Inhibition of a high affinity cyclic AMP phosphodiesterase and relaxation of canine tracheal smooth muscle. Biochem Pharmacol 1983; 31: 3403-3406.
22. Zurier RB, Weismann G, Hoffstein S. Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J Clin Invest 1974; 53: 297-309.
23. Nielson CP, Vestal RE, Sturm RJ, Heaslip R. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J Allergy Clin Immunol 1990; 86: 801-808.
24. Souness JE, Carter CM, Diocee BK, Hassall GA, Wood LJ, Turner NC. Characterization of guinea-pig eosinophil phosphodiesterase activity: assessment of its involvement in regulating Superoxide generation. Biochem Pharmacol 1991; 42: 937-945.
25. Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT. Regulation of Ig-induced eosinophil degranulation by adenosine 3′,5′-cyclic monophosphate. J Immunol 1991; 146: 2712-2718.
26. Barnes PJ. Cyclic nucleotides and phosphodiesterases and airway function. Eur Respir J 1995; 8: 457-462.
27. Derian CK, Santulli RJ, Rao PE, Solomon HF, Barrett JA. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators. J Immunol 1995; 154: 308-317.
28. Berends C, Dijkhuizen B, de Monchy JGR, Gerritsen J, Kauffman HF. Induction of low density and upregulation of CD11b expression of neutrophils and eosinophils by dextran sedimentation and centrifugation. J Immunol Methods 1994; 167: 183-193.
29. Fearon DT, Collins LA. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J Immunol 1983; 130: 370-375.
30. Repo H, Jansson S-E, Leirisalo-Repo M. Flow cytometric determination of CD11b upregulation in vivo. J Immunol Methods 1993; 164: 193-202.
31. Berends C, Hoekstra MO, Dijkhuizen B, de Monchy JGR, Gerritsen J, Kauffman HF. Expression of CD35 (CR1) and CD11b (CR3) on circulating neutrophils and eosinophils from allergic asthmatic children. Clin Exp Allergy 1993; 23: 926-933.
32. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989; 83: 1013-1026.
33. de Grooth BG, Terstappen LWM, Puppels GJ, Greve J. Light scattering polarization, a new parameter in flow cytometry. Cytometry 1987; 8: 539-544.
34. Altieri DC, Edgington TS. A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1). J Immunol 1988; 141: 2656-2660.
35. Spertini O, Kansas GF, Munro JM, Griffin JD, Tedder TF. Regulation of leukocyte migration by activation of the leukocyte adhesion molecule-1 (LAM-1), selectin. Nature 1991; 349: 691-694.
36. Dent G, Giembycz MA, Evans PM, Rabe KF, Barnes PJ. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta-adrenoceptor agonist, albuterol. J Pharmacol Exp Ther 1994; 271: 1167-1174.
37. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994; 343: 1006-1008.
38. Wollner A, Wollner S, Smith JB. Acting via A2 receptors, adenosine inhibits the upregulation of MAC-1 (CD11b/CD18) expression on fMLP-stimulated neutrophils. Am J Respir Cell Mol Biol 1993; 9: 179-185.
39. Brown GE, Reed EB, Lanser ME. Neutrophil CR3 expression and specific granule exocytosis are controlled by different signal transduction pathways. J Immunol 1991; 147: 965-971.
40. Kuehl FA Jr, Zanetti ME, Soderman D, Miller DK, Ham EA. Cyclic AMP-dependent regulation of lipid mediators in white cells: a unifying concept for explaining the efficacy of theophylline in asthma. Am Rev Respir Dis 1987; 136: 210-213.
41. Takayama H, Trenn G, Sitkovsky MV. Locus of inhibitory action of cAMP-dependent protein kinase in the antigen receptor triggered cytotoxic T-lymphocyte pathway. J Biol Chem 1988; 263: 2330-2336.
42. Della Bianca V, De Togni P, Grzeskowiak M, Vicentini LM, Di Virgilio F. Cyclic AMP inhibition of phosphoinositide turnover in human neutrophils. Biochim Biophys Acta 1986; 886: 441-447.
43. Verghese MW, Charles L, Jakoi L, Dillon SB, Snyderman R. Role of a guanine nucleotide regulatory protein in the activation of phospholipase C by different chemoattractants. J Immunol 1987; 138: 4374-4380.
44. 2+-independent route. J Immunol 1989; 142: 623-628.
45. Berger M, Birx DL, Wetzler EM, O'Shea J, Brown EJ, Cross AS. Calcium requirements for increased complement receptor expression during neutrophil activation. J Immunol 1985; 135: 1342-1348.
46. Shalit M, Von Allmen C, Atkins PC, Zweiman B. Platelet-activating factor increases expression of complement receptors on human neutrophils. J Leukoc Biol 1988; 44: 212-217.
47. Yukawa T, Kroegel C, Chanez P, et al. Effect of theophylline and adenosine on eosinophil function. Am Rev Respir Dis 1989; 140: 327-333.
48. Cronstein BN, Kramer SB, Weissmann G, Hirschhorn R. Adenosine: a physiological modulator of Superoxide anion generation of human neutrophils. J Exp Med 1983; 158: 1160-1177.
49. Liu MC, Hubbard WC, Proud D, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: cellular, mediator, and permeability changes. Am Rev Respir Dis 1991; 144: 51-58.